Semler Scientific, Inc.

    Semler Scientific, Inc.

    NNASDAQ:SMLR
    20.33
    USD
    0.00
    (0.00%)
    6.86P/E
    2012 Y
    2013 Y
    2014 Y
    2015 Y
    2016 Y
    2017 Y
    2018 Y
    2019 Y
    2020 Y
    2021 Y
    2022 Y
    2023 Y
    2024 Y
    TTM
    Revenue per Share
    0.43
    0.48
    0.89
    1.42
    1.45
    2.3
    3.54
    5.09
    5.86
    7.88
    8.43
    10.13
    7.79
    3.34
    Basic EPS, GAAP
    -1.01
    -0.47
    -1.1
    -1.72
    -0.5
    -0.28
    0.82
    2.34
    2.13
    2.56
    2.13
    3.06
    5.66
    4.37
    Free Cash Flow per Basic Share
    -0.72
    -0.35
    -1.04
    -1.06
    -0.51
    -0.06
    0.63
    1.71
    2.18
    2.26
    2.27
    3.05
    -22.87
    -39.6
    Dividend per Share
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Book Value per Share
    -2.54
    -1.99
    -3.38
    -4.54
    -4.86
    -4.89
    -3.52
    -0.98
    1.17
    3.7
    5.83
    8.88
    13.93
    10.84
    Tangible Book Value per Share
    -1.52
    -1.49
    0.84
    -0.22
    -0.57
    -0.48
    0.69
    2.03
    4.52
    6.77
    8.28
    10.66
    2.23
    -7.25
    Basic Weighted Avg Shares
    3
    5
    4
    5
    5
    5
    6
    6
    7
    7
    7
    7
    7
    11
    Sales/Revenue/Turnover
    1
    2
    4
    7
    7
    12
    21
    33
    39
    53
    57
    68
    56
    37
    Operating Margin (%)
    -201.42
    -93.4
    -119.42
    -120.25
    -29.04
    -6.85
    24.86
    32.68
    41.35
    36.67
    30.35
    33.72
    37.19
    -14.21
    Depreciation Expense
    - -
    - -
    - -
    - -
    - -
    1
    1
    1
    1
    1
    1
    1
    1
    - -
    Net Income, GAAP
    -3
    -2
    -5
    -9
    -3
    -2
    5
    15
    14
    17
    14
    21
    41
    48
    Effective Tax Rate (%)
    - -
    - -
    - -
    - -
    - -
    - -
    0.52
    - -
    15.04
    11.48
    19.03
    14.59
    14.59
    22.13
    Profit Margin (%)
    -228.61
    -98.2
    -124.21
    -121.43
    -34.36
    -12.13
    23.33
    46.03
    36.28
    32.48
    25.27
    30.19
    72.65
    130.8
    Working Capital
    - -
    -1
    3
    -2
    -2
    -2
    3
    6
    22
    41
    42
    60
    16
    26
    LT Debt
    - -
    - -
    - -
    - -
    3
    2
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    96
    Total Equity
    -4
    - -
    3
    -1
    -3
    -3
    4
    13
    30
    46
    56
    72
    231
    460
    Return on Invested Capital (%)
    - -
    - -
    - -
    - -
    - -
    - -
    234.63
    - -
    62.07
    44.38
    26.61
    29.89
    11.72
    -1.23
    Return on Capital (%)
    - -
    - -
    - -
    - -
    - -
    - -
    -23.65
    - -
    2,070.51
    104.67
    44.28
    41.4
    50.88
    31.88
    Return on Common Equity (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    105.71
    44.68
    41.57
    50.96
    50.52

    Capital Structure

    USD

    •

    in mil. unless spec.
    Mar'25
    Jun'25
    Sep'25
    ST Debt
    - -
    - -
    20
    LT Borrowings
    96
    96
    96
    LT Finance Leases
    - -
    - -
    - -
    Preferred Equity and Hybrid Capital
    - -
    - -
    - -
    Shares Outstanding
    10
    14
    15
    Market Capitalization
    286
    353
    332

    Working Capital

    USD

    •

    in mil. unless spec.
    Mar'25
    Jun'25
    Sep'25
    Total Current Assets
    18
    22
    54
    Cash, Cash Equivalents & STI
    10
    13
    10
    Accounts Receivable, Net
    3
    3
    3
    Inventories
    - -
    1
    - -
    Total Current Liabilities
    36
    37
    27
    Payables & Accruals
    33
    33
    3
    ST Debt
    - -
    - -
    20
    Deferred Revenue
    1
    1
    - -

    Growth Rates

    USD

    •

    in mil. unless spec.

    (avg. rate of change)

    10 years
    5 years
    1 year
    Total Equity
    43.21%
    90.67%
    221.4%
    Free Cash Flow
    -196.41%
    -167.15%
    -906.46%
    Net Income, GAAP
    -11.24%
    28.28%
    98.7%
    Sales/Revenue/Turnover
    35.63%
    12.98%
    -17.44%
    Total Cash Common Dividend
    - -
    - -
    - -

    Quarterly Revenue

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    18
    19
    16
    15
    68
    2024
    16
    14
    14
    12
    56
    2025
    9
    8
    7
    - -
    - -

    Quarterly Earnings Per Share

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    0.74
    0.88
    0.82
    0.62
    3.06
    2024
    0.88
    - -
    0.8
    3.64
    5.66
    2025
    -6.74
    5.71
    1.14
    - -
    - -

    Quarterly Dividends Per Share

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    - -
    - -
    - -
    - -
    - -
    2024
    - -
    - -
    - -
    - -
    - -
    2025
    - -
    - -
    - -
    - -
    - -

    Company Description

    Company Profile APIChatGPT
    Address
    Similar Companies
    Business

    Company News

    Company News APIChatGPT

    • newsfilecorp.com

      Kuehn Law Encourages Investors of Semler Scientific to Contact Law Firm

    • defenseworld.net

      Analysts Set Semler Scientific Inc. (NASDAQ:SMLR) Price Target at $74.25

    • defenseworld.net

      Generali Asset Management SPA SGR Grows Stock Holdings in Semler Scientific Inc. $SMLR

    • defenseworld.net

      Analysts Set Semler Scientific Inc. (NASDAQ:SMLR) PT at $74.25

    • defenseworld.net

      Semler Scientific (NASDAQ:SMLR) & Vasamed (OTCMKTS:VSMD) Head-To-Head Survey

    • prnewswire.com

      Semler Scientific Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Semler Scientific, Inc. - SMLR

    • youtube.com

      Crypto's Hottest Trade Crumples

    • globenewswire.com

      SMLR Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Proposed Merger of Semler Scientific With Strive Asset Management

    • prnewswire.com

      Semler Scientific® to Release Third Quarter 2025 Financial Results

    • globenewswire.com

      Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of October 28, 2025 in Semler Scientific, Inc. Lawsuit – SMLR

    • prnewswire.com

      Semler Scientific Deadline: SMLR Investors Have Opportunity to Lead Semler Scientific, Inc. Securities Fraud Lawsuit First Filed by The Rosen Law Firm

    • globenewswire.com

      SMLR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Semler Scientific, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

    • businesswire.com

      SMLR Deadline Today: Rosen Law Firm Encourages Semler Scientific, Inc. Investors to Secure Counsel Before Important October 28 Deadline in Securities Class Action First Filed by the Firm – SMLR

    • prnewswire.com

      INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Semler Scientific, Inc. of Class Action Lawsuit and Upcoming Deadlines - SMLR

    • prnewswire.com

      SMLR FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Investors of the Semler Scientific Upcoming Lead Plaintiff Deadline on Tuesday, October 28, 2025

    • prnewswire.com

      Semler Scientific, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before October 28, 2025 to Discuss Your Rights - SMLR

    • seekingalpha.com

      Strive: Strategic Expansion Meets Bitcoin Tailwinds -- Set For A Solid 2025 Finish

    • globenewswire.com

      SEMLER FINAL DEADLINE ALERT: Bragar Eagel & Squire, P.C. Urges Semler Stockholders to Contact the Firm Before October 28th

    • globenewswire.com

      Portnoy Law Firm Announces Class Action on Behalf of Semler Scientific, Inc. Investors

    • businesswire.com

      Deadline Soon: Semler Scientific Inc. (SMLR) Shareholders Who Lost Money Urged to Contact the Law Offices of Frank R. Cruz About Securities Fraud Lawsuit